Immunocompromised Swiss Cohorts Based Trial Platform
Clinical trial NCT04805125 · COMPLETED
Trial details
- NCT number
- NCT04805125
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-19
- Primary completion
- 2023-09-23
- Enrollment
- 610
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.